세계의 치과용 마취제 시장 : 시장 예측 : 마취제 유형별, 투여 경로별, 용도별, 최종 사용자별, 지역별 분석(-2032년)

According to Stratistics MRC, the Global Dental Anesthetics Market is accounted for $2.1 billion in 2025 and is expected to reach $3.1 billion by 2032, growing at a CAGR of 5.7% during the forecast period. Dental anesthetics are drugs that reduce pain and suffering during dental treatments by numbing particular parts of the mouth. Depending on the patient's demands and the intensity of the surgery, they can be topical, local, or general anesthetics. Dental anesthetics, which are frequently used in root canals, fillings, and extractions, block nerve signals in specific regions, enabling dentists to treat patients securely, comfortably, and without causing them any pain or discomfort.

According to data from the World Health Organization, oral diseases affected approximately 3.5 billion people globally, with around 2 billion suffering from caries of permanent teeth and 514 million children affected by caries of primary teeth.

Market Dynamics:

Driver:

Increasing prevalence of dental diseases

The increasing incidence of dental illnesses, including caries and periodontal diseases, significantly propels the dental anesthetics market. As knowledge of oral health rises, more individuals are pursuing dental treatments, encompassing regular operations such as fillings and extractions. These procedures require efficient anesthetic methods to guarantee patient comfort. Furthermore, the increasing prevalence of dental problems in youngsters enhances the demand for anesthetics. Global accessibility to dental care and advancements in diagnostic technology also significantly boost market growth.

Restraint:

Potential side effects and complications

The dental anesthetics industry encounters difficulties stemming from possible adverse effects and issues linked to its application. Concerns such as allergic reactions, toxicity, and extended numbness may dissuade patients from selecting specific anesthetic agents. Moreover, inappropriate administration may result in nerve injury or systemic issues, heightening concerns among healthcare providers. These dangers require rigorous oversight and expert management, constraining the broad utilization of certain anesthetics. Furthermore, patient anxiety concerning anesthesia-related discomfort may hinder market expansion.

Opportunity:

Development of advanced anesthetic agents and delivery systems

Advancements in anesthetic formulations and delivery technologies provide substantial growth prospects. Innovations include computer-controlled local anesthesia delivery (CCLAD) devices that enhance precision and reduce pain during injections. Furthermore, investigations into more durable and safer formulations improve efficacy while minimizing unwanted effects. These advancements address the increasing demand for non-invasive dental treatments, especially in cosmetic dentistry and pediatric care. Moreover, partnerships between manufacturers and healthcare professionals foster innovation in anesthetic solutions customized for various patient requirements.

Threat:

Stringent regulatory approval processes

Strict regulatory procedures for the approval of dental anesthetics hinder market expansion. Manufacturers must traverse intricate compliance regulations to guarantee product safety and efficacy, sometimes delaying product launches and escalating prices. Furthermore, discrepancies in rules among regions hamper worldwide distribution plans. These obstacles constrain innovation among smaller entities that may lack the resources for comprehensive clinical trials and regulatory applications. Additionally, increased examination of negative impacts exacerbates the approval process.

Covid-19 Impact:

The Covid-19 outbreak adversely affected the dental anesthetics business because of a decline in dental treatments during lockdowns. Global supply chain issues impacted the availability of anesthetic drugs. Additionally, patients' reluctance to attend clinics due to health concerns led to a decrease in regular procedures requiring anesthetics. Post-pandemic recovery is due to increased awareness of oral health and demographic changes that increase the need for dental care. Moreover, throughout the forecast period, we expect advancements in teledentistry and minimally invasive techniques to enhance market expansion.

The local anesthetics segment is expected to be the largest during the forecast period

The local anesthetics segment is expected to account for the largest market share during the forecast period owing to their extensive application in common dental procedures, such as fillings and extractions. They provide benefits including fewer systemic adverse effects and economic efficiency relative to general anesthesia. Lidocaine continues to be the benchmark for local anesthesia, owing to its safety and efficacy. Furthermore, technological innovations such as single-tooth anesthetic devices improve accuracy and patient comfort during delivery. The rising need for painless treatments propels market growth, rendering local anesthetics essential in contemporary dentistry.

The ambulatory surgical centers (ASCs) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the ambulatory surgical centers (ASCs) segment is predicted to witness the highest growth rate owing to its efficacy in providing outpatient operations at reduced prices compared to conventional hospital environments. Ambulatory Surgical Centers (ASCs) address the increasing need for less invasive procedures that offer expedited recovery, in accordance with patient preferences for convenience. Furthermore, innovations in medical technology allow ASCs to conduct intricate surgeries securely under anesthesia. Collaborations between ASCs and healthcare providers optimize operations and improve care quality, thereby increasing their acceptance in many countries.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to heightened awareness of oral health and significant investments in dental care infrastructure. The area benefits from sophisticated diagnostic technology and an increasing elderly population necessitating regular dental procedures under anesthesia. Furthermore, the increasing demand for cosmetic dentistry substantially drives market growth. The involvement of pivotal entities fostering innovation guarantees continuous growth via strategic partnerships and product introductions customized to regional demands.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to heightened public awareness regarding oral health and rapid urbanization. Increasing disposable incomes facilitate access to modern dental care services in rising economies such as China and India. Moreover, governmental actions that advance healthcare infrastructure development improve access to effective treatments necessitating anesthesia. The expanding middle class in the region is increasing the need for cosmetic dentistry utilizing contemporary anesthetic methods.

Key players in the market

Some of the key players in Dental Anesthetics Market include Dentsply Sirona, Septodont, Pierrel S.p.A., Henry Schein Inc., Hikma Pharmaceuticals PLC, 3M Company, Primex Pharmaceuticals, Aspen Group, Laboratorios Inibsa, Laboratorios Normon, Cetylite Inc., Zeyco, Milestone Scientific, Centrix, Inc., Crosstex International, Inc., and HANSAmed Limited.

Key Developments:

In March 2025, Dentsply Sirona, the world's largest diversified manufacturer of professional dental products and technologies, and Rapid Shape, a leading innovator in German-engineered dental 3D printing technology are pleased to announce a collaboration to validate the Lucitone Digital Print Denture workflow and material system on Rapid Shape's 3D printing solutions for digital denture manufacturing.

In May 2024, Laboratorios Inibsa Launched Prestoject(R) Dental Syringes for enhanced precision in administering anesthesia. Prestoject(R) Dental Syringes are meticulously designed to provide a solution that sets a new standard for comfortable and successful dental anaesthesia.

In August 2023, 3M announced it has completed the sale of certain assets from its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A. ("Pierrel"), a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments. These local anesthetic products, sold primarily in Europe and Asia, include products sold under the Ubistesin(TM), Xylestesin(TM) and Mepivastesin(TM) brands as well as related syringe and needle products. These were formerly a part of the dental materials business in 3M's Oral Care Solutions Division.

Type of Anesthetics Covered:

• Local Anesthetics
• General Anesthetics
• Sedative

Route of Administrations Covered:

• Injectable
• Topical

Applications Covered:

• Restorative Dentistry
• Periodontics
• Oral Surgery
• Prosthodontics
• Implantology
• Pediatric Dentistry
• Cosmetic Dentistry
• Other Applications

End Users Covered:

• Dental Clinics
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Dental Research Institutes

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Dental Anesthetics Market, By Type of Anesthetic

• 5.1 Introduction
• 5.2 Local Anesthetics
  • 5.2.1 Amide-based Local Anesthetics
    • 5.2.1.1 Lidocaine
    • 5.2.1.2 Articaine
    • 5.2.1.3 Prilocaine
    • 5.2.1.4 Bupivacaine
    • 5.2.1.5 Mepivacaine
    • 5.2.1.6 Other Amide-based Anesthetics
  • 5.2.2 Ester-based Local Anesthetics
    • 5.2.2.1 Procaine
    • 5.2.2.2 Benzocaine
    • 5.2.2.3 Tetracaine
    • 5.2.2.4 Other Ester-based Anesthetics
• 5.3 General Anesthetics
  • 5.3.1 Inhalation General Anesthetics
  • 5.3.2 Intravenous General Anesthetics
• 5.4 Sedative
  • 5.4.1 Nitrous Oxide
  • 5.4.2 Oral Sedatives
  • 5.4.3 Intravenous Sedatives

6 Global Dental Anesthetics Market, By Route of Administration

• 6.1 Introduction
• 6.2 Injectable
• 6.3 Topical
  • 6.3.1 Gels
  • 6.3.2 Sprays
  • 6.3.3 Patches

7 Global Dental Anesthetics Market, By Application

• 7.1 Introduction
• 7.2 Restorative Dentistry
• 7.3 Periodontics
• 7.4 Oral Surgery
• 7.5 Prosthodontics
• 7.6 Implantology
• 7.7 Pediatric Dentistry
• 7.8 Cosmetic Dentistry
• 7.9 Other Applications

8 Global Dental Anesthetics Market, By End User

• 8.1 Introduction
• 8.2 Dental Clinics
• 8.3 Hospitals
• 8.4 Ambulatory Surgical Centers (ASCs)
• 8.5 Dental Research Institutes

9 Global Dental Anesthetics Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Dentsply Sirona
• 11.2 Septodont
• 11.3 Pierrel S.p.A.
• 11.4 Henry Schein Inc.
• 11.5 Hikma Pharmaceuticals PLC
• 11.6 3M Company
• 11.7 Primex Pharmaceuticals
• 11.8 Aspen Group
• 11.9 Laboratorios Inibsa
• 11.10 Laboratorios Normon
• 11.11 Cetylite Inc.
• 11.12 Zeyco
• 11.13 Milestone Scientific
• 11.14 Centrix, Inc.
• 11.15 Crosstex International, Inc.
• 11.16 HANSAmed Limited